Cineverse (CNVS) Financials

Cineverse logo
$1.75 -0.08 (-4.59%)
As of 10:32 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Cineverse

Annual Income Statements for Cineverse

This table shows Cineverse's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-21 6.51 -19 -17 -15 -63 1.77 -10 -22 3.25 -9.19
Consolidated Net Income / (Loss)
-21 6.51 -19 -16 -15 -63 2.27 -9.69 -21 3.76 -8.66
Net Income / (Loss) Continuing Operations
-21 -15 -19 -16 -15 -63 2.27 -9.69 -21 3.76 -8.66
Total Pre-Tax Income
-21 6.76 -18 -16 -14 -63 1.48 -9.58 -21 3.87 -12
Total Operating Income
-21 6.76 0.72 -5.62 -4.35 -13 -0.93 -8.92 -16 7.92 -15
Total Gross Profit
72 64 67 36 39 31 56 68 49 78 66
Total Revenue
104 90 68 54 39 31 56 68 49 78 66
Operating Revenue
104 90 68 54 39 31 56 68 49 78 66
Total Cost of Revenue
32 26 0.99 18 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
93 57 66 41 44 88 57 77 65 70 81
Selling, General & Admin Expense
33 24 28 28 33 38 30 37 28 28 43
Depreciation Expense
37 28 12 8.12 6.62 4.40 4.57 3.76 3.77 3.80 5.97
Other Operating Expenses / (Income)
- - 20 - 0.76 44 21 36 19 39 32
Total Other Income / (Expense), net
0.00 0.00 -19 -10 -10 -6.23 2.41 -0.66 -5.56 -4.05 3.66
Interest Expense
- - 19 10 7.26 5.59 -1.82 -1.19 1.07 4.37 0.46
Interest & Investment Income
- - 0.06 0.04 0.02 0.04 0.59 -1.83 - - 0.00
Other Income / (Expense), net
- - -0.12 -0.10 -2.83 -0.68 0.00 -0.01 -4.49 0.31 4.11
Income Tax Expense
0.35 0.25 0.40 0.30 0.31 -0.32 -0.79 0.12 0.01 0.11 -2.84
Preferred Stock Dividends Declared
- - 0.36 0.36 0.36 0.36 0.44 0.35 0.35 0.36 0.36
Net Income / (Loss) Attributable to Noncontrolling Interest
- - -0.04 -0.03 0.01 -0.09 0.06 0.04 0.14 0.16 0.18
Basic Earnings per Share
- - ($0.81) ($0.44) - ($0.49) $0.21 ($1.13) ($1.78) $0.18 ($0.49)
Weighted Average Basic Shares Outstanding
6.47M 8.05M 23.10M 37.92M 44.00M 127.79M 8.53M 8.89M 12.25M 15.81M 18.78M
Diluted Earnings per Share
- - ($0.81) ($0.44) ($0.34) ($0.49) $0.20 ($1.13) ($1.78) $0.16 ($0.49)
Weighted Average Diluted Shares Outstanding
6.47M 8.05M 23.10M 37.92M 44.00M 127.79M 8.69M 8.89M 12.25M 17.82M 18.78M
Weighted Average Basic & Diluted Shares Outstanding
6.47M 8.05M 23.10M 37.92M 44.00M 127.79M 176.74M 11.68M 15.61M 17.11M 23.42M

Quarterly Income Statements for Cineverse

This table shows Cineverse's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - 15 18 - - - 22
Net Income / (Loss) Attributable to Common Shareholders
-15 -3.16 -1.38 7.02 0.76 -3.65 -5.68 -1.01 1.15 -5.77 3.17
Consolidated Net Income / (Loss)
-15 -3.05 -1.20 7.16 0.86 -3.52 -5.55 -0.88 1.28 -5.69 3.25
Net Income / (Loss) Continuing Operations
-15 -3.05 -1.20 7.16 0.86 -3.52 -5.55 -0.88 1.28 -5.69 3.25
Total Pre-Tax Income
-15 -3.04 -1.20 7.17 0.94 -3.50 -5.53 -0.86 -1.62 -5.67 3.36
Total Operating Income
-14 -2.78 -0.86 9.44 2.13 -3.70 -5.41 -0.66 -5.39 -5.12 4.05
Total Gross Profit
9.86 9.13 13 41 16 11 12 16 26 31 26
Total Revenue
9.86 9.13 13 41 16 11 12 16 26 31 26
Operating Revenue
9.86 9.13 13 41 16 11 12 16 26 31 26
Total Cost of Revenue
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses
24 12 14 31 13 15 18 17 31 36 22
Selling, General & Admin Expense
6.82 6.56 6.36 9.36 5.40 8.95 11 11 12 12 10
Depreciation Expense
0.98 0.86 0.97 0.95 1.01 1.06 1.15 1.20 2.56 2.82 2.76
Other Operating Expenses / (Income)
2.03 4.48 6.26 21 7.04 4.81 5.21 5.05 17 21 9.01
Total Other Income / (Expense), net
-0.68 -0.27 -0.34 -2.27 -1.18 0.20 -0.12 -0.20 3.77 -0.55 -0.69
Interest Expense
0.29 0.43 0.34 2.34 1.26 -0.28 0.15 0.20 0.39 0.56 0.70
Other Income / (Expense), net
-0.40 0.17 0.00 0.07 0.07 -0.08 0.03 -0.01 4.16 0.01 0.01
Income Tax Expense
-0.00 0.01 0.01 0.01 0.09 0.01 0.02 0.02 -2.90 0.02 0.11
Preferred Stock Dividends Declared
0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.08 0.08
Net Income / (Loss) Attributable to Noncontrolling Interest
0.05 0.02 0.08 0.05 0.01 0.04 0.04 0.05 0.04 0.00 0.00
Basic Earnings per Share
($1.21) ($0.20) ($0.09) $0.38 $0.05 ($0.21) ($0.31) ($0.05) $0.08 ($0.28) $0.13
Weighted Average Basic Shares Outstanding
12.25M 15.70M 15.72M 15.88M 15.81M 16.99M 18.45M 19.22M 18.78M 20.67M 24.28M
Diluted Earnings per Share
($1.21) ($0.20) ($0.09) $0.34 $0.05 ($0.21) ($0.31) ($0.05) $0.08 ($0.28) $0.11
Weighted Average Diluted Shares Outstanding
12.25M 15.70M 15.72M 17.77M 17.82M 16.99M 18.45M 19.22M 18.78M 20.67M 32.34M
Weighted Average Basic & Diluted Shares Outstanding
15.61M 15.71M 15.87M 15.98M 17.11M 19.08M 19.15M 19.57M 23.42M 23.77M 26.82M

Annual Cash Flow Statements for Cineverse

This table details how cash moves in and out of Cineverse's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
6.48 -13 5.39 -0.08 -3.58 2.56 -4.79 -5.91 -1.99 8.73 -11
Net Cash From Operating Activities
26 32 22 11 7.76 -20 4.88 -8.80 -11 17 -26
Net Cash From Continuing Operating Activities
26 32 22 11 7.76 -20 4.88 -8.80 -11 17 -26
Net Income / (Loss) Continuing Operations
-43 -15 -19 -16 -15 -63 2.27 -9.69 -21 3.76 -8.66
Consolidated Net Income / (Loss)
-43 -15 -19 -16 -15 -63 2.27 -9.69 -21 3.76 -8.66
Depreciation Expense
43 33 18 14 9.39 6.92 4.57 3.83 3.77 3.80 5.97
Amortization Expense
2.46 2.69 2.04 1.89 1.22 1.22 0.00 0.10 0.19 0.47 0.38
Non-Cash Adjustments To Reconcile Net Income
24 7.23 8.75 9.85 4.36 49 4.95 6.79 13 -0.09 -4.90
Changes in Operating Assets and Liabilities, net
-1.86 3.54 12 1.86 7.52 -14 -6.91 -9.82 -5.92 9.43 -19
Net Cash From Investing Activities
-1.39 -0.49 -0.93 -1.97 -1.25 -1.71 -12 -1.27 -0.53 -0.64 -14
Net Cash From Continuing Investing Activities
-1.39 -0.49 -0.93 -1.97 -1.25 -1.71 -12 -1.27 -0.53 -0.64 -14
Purchase of Property, Plant & Equipment
-1.38 -0.48 -0.93 -1.42 -1.24 -0.06 -0.32 -1.27 -1.07 -0.07 -3.95
Acquisitions
-0.01 -0.01 -0.01 -0.55 -0.01 -2.55 -12 - - 0.00 -9.97
Sale and/or Maturity of Investments
- - - - 0.00 0.82 0.01 0.00 0.54 0.54 0.00
Other Investing Activities, net
- - - - - - - - - -1.11 -0.41
Net Cash From Financing Activities
-18 -44 -16 -9.20 -10 24 2.64 4.16 9.14 -8.00 30
Net Cash From Continuing Financing Activities
-18 -44 -16 -9.20 -10 24 2.64 4.16 9.14 -8.00 30
Repayment of Debt
-69 -58 -54 -25 -39 -21 -1.96 -26 -43 -74 -53
Repurchase of Common Equity
-14 0.00 -0.16 - - - - - 0.00 -0.42 -0.81
Issuance of Debt
64 14 10 15 24 2.15 0.00 31 44 67 75
Issuance of Common Equity
- - 28 0.00 5.85 43 12 0.00 8.52 -0.04 4.47
Other Financing Activities, net
- - - - 0.00 - -7.79 -0.67 -0.58 -0.98 4.15
Cash Interest Paid
- - - - - - 0.78 0.20 0.38 1.00 0.67
Cash Income Taxes Paid
- - - - - - 0.08 0.10 0.06 0.03 0.07

Quarterly Cash Flow Statements for Cineverse

This table details how cash moves in and out of Cineverse's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-0.37 -1.27 -1.52 3.66 7.86 -12 0.38 0.08 0.93 0.95 -0.76
Net Cash From Operating Activities
-1.31 -2.34 -0.09 7.37 12 -14 -7.17 -1.61 -3.19 -0.99 -2.86
Net Cash From Continuing Operating Activities
-1.31 -2.35 -0.08 7.37 12 -14 -7.17 -1.61 -3.19 -0.99 -2.86
Net Income / (Loss) Continuing Operations
-15 -3.05 -1.20 7.16 0.86 -3.52 -5.55 -0.88 1.28 -5.69 3.25
Consolidated Net Income / (Loss)
-15 -3.05 -1.20 7.16 0.86 -3.52 -5.55 -0.88 1.28 -5.69 3.25
Depreciation Expense
0.98 0.86 0.97 0.95 1.01 1.06 1.15 1.20 2.56 2.82 2.76
Amortization Expense
0.09 0.10 0.10 0.11 0.16 0.08 0.08 0.03 0.19 0.35 0.46
Non-Cash Adjustments To Reconcile Net Income
15 -2.59 2.64 0.19 -0.33 -1.23 -2.13 2.92 -4.19 0.15 -9.12
Changes in Operating Assets and Liabilities, net
-2.99 2.34 -2.59 -1.04 11 -11 -0.73 -4.89 -3.03 1.38 -0.21
Net Cash From Investing Activities
-0.05 0.15 -0.97 0.17 0.02 -0.20 -0.84 -0.58 -13 -1.95 -1.79
Net Cash From Continuing Investing Activities
-0.05 0.15 -0.97 0.17 0.02 -0.20 -0.84 -0.58 -13 -1.95 -1.79
Purchase of Property, Plant & Equipment
-0.43 - - 0.82 -0.02 -0.02 -0.50 -0.08 -3.36 -0.27 -0.39
Acquisitions
- - - - - 0.00 - - - -1.53 -1.35
Other Investing Activities, net
- -0.05 -0.11 -0.90 -0.05 -0.18 - -0.50 0.44 -0.15 -0.05
Net Cash From Financing Activities
0.98 0.93 -0.46 -3.88 -4.59 2.57 8.40 2.27 17 3.90 3.89
Net Cash From Continuing Financing Activities
0.98 0.93 -0.46 -3.88 -4.59 2.57 8.40 2.27 17 3.90 3.89
Repayment of Debt
-14 -18 -12 -24 -20 -5.70 -17 -15 -15 -17 -16
Issuance of Debt
15 19 12 20 17 9.33 20 17 29 19 19
Issuance of Common Equity
-0.02 - - - -0.04 0.00 - - 3.83 2.47 1.19
Other Financing Activities, net
-0.29 -0.14 -0.33 0.03 -0.55 -1.06 5.38 - -0.17 -0.41 -0.41
Cash Interest Paid
0.14 0.24 -0.02 0.72 0.06 0.04 0.06 0.22 0.35 0.58 -0.26
Cash Income Taxes Paid
0.01 0.05 0.02 -0.03 -0.00 0.03 0.06 0.02 -0.03 0.05 0.03

Annual Balance Sheets for Cineverse

This table presents Cineverse's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
209 151 121 99 110 75 105 88 64 73 130
Total Current Assets
102 86 74 65 57 43 52 38 33 38 51
Cash & Equivalents
25 13 18 18 14 17 13 7.15 5.17 14 3.39
Accounts Receivable
53 54 38 36 35 21 31 21 15 16 39
Other Current Assets
5.57 5.66 6.80 2.34 1.99 1.38 2.35 9.58 12 8.39 8.79
Plant, Property, & Equipment, net
62 33 21 14 7.97 3.50 1.98 1.83 2.28 2.88 3.91
Total Noncurrent Assets
46 32 26 20 45 29 50 49 29 32 76
Goodwill
8.70 8.70 8.70 8.70 8.70 8.70 21 21 6.80 6.80 21
Intangible Assets
26 20 15 9.69 6.92 9.86 20 20 18 18 44
Other Noncurrent Operating Assets
9.88 1.26 1.00 1.00 6.38 3.80 2.35 2.69 4.25 6.59 10
Total Liabilities & Shareholders' Equity
209 151 121 99 110 75 105 88 64 73 130
Total Liabilities
282 222 143 135 130 60 64 49 32 35 87
Total Current Liabilities
101 102 76 114 128 57 57 45 31 34 63
Short-Term Debt
29 26 5.29 43 49 9.74 0.00 4.92 6.30 0.00 9.44
Accounts Payable
69 74 69 69 77 47 52 35 21 31 39
Current Deferred Revenue
2.90 2.46 1.82 1.69 1.65 0.92 0.20 0.23 0.44 0.18 0.13
Other Current Liabilities
- - - 0.00 0.59 0.09 4.77 5.65 3.70 3.14 14
Total Noncurrent Liabilities
182 120 67 22 1.71 2.18 6.69 3.58 0.98 0.29 24
Long-Term Debt
170 114 63 19 0.00 2.15 - - - 0.00 13
Other Noncurrent Operating Liabilities
0.00 0.41 0.31 0.21 0.79 0.03 6.69 3.58 0.98 0.29 11
Commitments & Contingencies
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-73 -71 -22 -37 -19 16 41 39 32 38 43
Total Preferred & Common Equity
-72 -69 -21 -35 -18 17 42 40 33 39 44
Preferred Stock
3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.56
Total Common Equity
-75 -73 -25 -39 -22 14 39 37 30 35 41
Common Stock
270 287 366 369 401 499 523 531 546 549 564
Retained Earnings
-342 -360 -379 -396 -411 -474 -472 -482 -504 -501 -510
Treasury Stock
-2.84 0.00 -12 -12 -12 -12 -12 -12 -12 -12 -13
Accumulated Other Comprehensive Income / (Loss)
-0.06 -0.04 -0.04 0.01 0.09 -0.07 -0.16 -0.40 -0.35 -0.31 -0.28
Noncontrolling Interest
-1.19 -1.21 -1.26 -1.29 -1.28 -1.36 -1.30 -1.26 -1.12 -0.96 -0.95

Quarterly Balance Sheets for Cineverse

This table presents Cineverse's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025 6/30/2026 9/30/2026
Total Assets
85 83 62 61 81 62 62 69 135 130
Total Current Assets
35 36 32 30 50 25 23 29 56 49
Cash & Equivalents
8.62 5.54 3.96 2.43 6.08 1.99 2.34 2.46 4.32 3.55
Accounts Receivable
12 16 9.26 15 34 16 14 17 43 34
Other Current Assets
14 14 18 13 10 6.81 7.17 9.37 8.16 11
Plant, Property, & Equipment, net
2.07 2.07 2.72 2.93 2.93 2.97 3.07 3.53 4.16 4.40
Total Noncurrent Assets
48 45 28 27 27 34 36 36 75 77
Goodwill
21 21 6.80 6.80 6.80 6.80 6.80 6.80 21 21
Intangible Assets
19 19 18 18 18 18 18 18 42 41
Other Noncurrent Operating Assets
3.67 4.10 3.05 2.75 2.49 8.46 10 11 12 14
Total Liabilities & Shareholders' Equity
85 83 62 61 81 62 62 69 135 130
Total Liabilities
39 40 33 32 44 25 25 31 95 80
Total Current Liabilities
35 37 32 31 44 25 25 31 74 59
Short-Term Debt
4.90 4.93 7.79 7.78 3.85 3.63 6.65 8.28 11 11
Accounts Payable
26 27 20 20 36 21 18 22 43 37
Current Deferred Revenue
0.27 0.25 0.33 0.35 0.33 0.56 0.00 0.00 0.09 0.37
Other Current Liabilities
4.26 4.50 4.06 3.31 3.58 0.19 0.34 0.30 20 9.71
Total Noncurrent Liabilities
3.57 3.23 0.48 0.43 0.35 0.24 0.26 0.18 21 21
Long-Term Debt
- - - - - - - - 13 14
Other Noncurrent Operating Liabilities
3.57 3.23 0.48 0.43 0.35 0.24 0.26 0.18 8.09 6.73
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
46 43 29 29 36 36 37 38 40 51
Total Preferred & Common Equity
47 44 31 30 37 37 38 39 40 51
Preferred Stock
3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.56 3.25 2.93
Total Common Equity
44 41 27 26 34 34 34 35 37 48
Common Stock
542 543 547 547 548 552 558 560 566 574
Retained Earnings
-486 -489 -507 -509 -502 -505 -510 -511 -516 -513
Treasury Stock
-12 -12 -12 -12 -12 -13 -13 -13 -13 -13
Accumulated Other Comprehensive Income / (Loss)
-0.41 -0.42 -0.29 -0.30 -0.31 -0.29 -0.32 -0.28 -0.30 -0.31
Noncontrolling Interest
-1.21 -1.17 -1.10 -1.02 -0.97 -0.92 -0.87 -0.82 0.00 0.00

Annual Metrics And Ratios for Cineverse

This table displays calculated financial ratios and metrics derived from Cineverse's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
235,411,386.00 10,525,001.00 34,947,790.00 35,678,248.00 40,290,640.00 165,953,762.00 174,871,216.00 179,092,441.00 13,327,960.00 15,979,558.00 19,569,866.00
DEI Adjusted Shares Outstanding
1,177,057.00 526,250.00 1,747,390.00 1,783,912.00 2,014,532.00 8,297,688.00 8,743,561.00 8,954,622.00 13,327,960.00 15,979,558.00 19,569,866.00
DEI Earnings Per Adjusted Shares Outstanding
-18.26 12.36 -10.76 -9.30 -7.49 -7.61 0.20 -1.13 -1.63 0.20 -0.47
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.98% -13.46% -25.12% -20.90% -26.61% -20.04% 78.41% 21.36% -27.78% 59.13% -15.92%
EBITDA Growth
-32.00% 74.95% -51.89% -51.89% -65.38% -274.97% 160.58% -237.37% -224.41% 177.02% -137.56%
EBIT Growth
-130.40% 131.95% -91.08% -1,047.60% -25.55% -97.30% 93.47% -866.77% -126.00% 140.79% -234.10%
NOPAT Growth
-139.15% 143.95% -92.22% -877.04% 22.59% -209.80% 84.98% -340.80% -76.01% 170.13% -237.66%
Net Income Growth
33.19% 130.27% -384.40% 12.08% 9.47% -327.23% 103.61% -526.86% -119.36% 117.70% -329.99%
EPS Growth
0.00% 0.00% 0.00% 45.68% 22.73% -44.12% 103.61% -526.86% -57.52% 108.99% -406.25%
Operating Cash Flow Growth
176.89% 24.29% -29.34% -50.49% -30.00% -357.76% 124.39% -280.28% -20.42% 263.99% -252.54%
Free Cash Flow Firm Growth
41.33% 23.35% -46.19% -45.20% -17.42% -267.33% 19.99% 4.29% 25.83% 235.72% -384.25%
Invested Capital Growth
-36.00% -45.80% -50.72% -71.43% -203.89% 153.87% 365.21% 51.70% 5.18% -28.34% 159.80%
Revenue Q/Q Growth
-4.06% -3.85% -2.76% -9.48% -1.38% -9.39% 18.09% -5.95% -5.18% 7.88% 18.79%
EBITDA Q/Q Growth
31.12% -8.39% 4.03% -41.26% 151.02% 80.51% -91.94% -149.53% -130.44% 398.04% -64.79%
EBIT Q/Q Growth
20.61% 3.29% 118.65% -649.95% 61.67% 63.63% -102.37% -50.03% -86.64% 198.55% -44.90%
NOPAT Q/Q Growth
20.61% -0.02% 122.36% -640.71% 35.73% -32.00% 48.40% -20.93% -229.21% 234.28% -98.35%
Net Income Q/Q Growth
55.46% -30.35% -184.75% -62.63% 53.02% -37.63% 202.90% -8.39% -120.07% 131.99% 4.66%
EPS Q/Q Growth
0.00% 0.00% -268.18% -62.96% 33.33% -44.12% 202.90% -8.39% -125.32% 120.51% 2.00%
Operating Cash Flow Q/Q Growth
99.50% -9.53% 5.73% -24.23% -22.94% -39.60% 222.05% -13.23% -4.03% 377.20% -144.39%
Free Cash Flow Firm Q/Q Growth
14.47% -9.01% -1.63% -17.05% -19.15% -57.39% -33.07% 18.00% 22.35% 1,060.76% -231.77%
Invested Capital Q/Q Growth
-13.07% -15.42% -20.24% -51.38% -77.20% 96.06% 61.56% 10.98% -19.68% -30.32% 42.24%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
69.24% 70.87% 98.54% 66.86% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
23.47% 47.44% 30.48% 18.54% 8.75% -19.13% 6.50% -7.35% -33.03% 15.99% -7.14%
Operating Margin
-20.25% 7.48% 1.07% -10.49% -11.07% -42.88% -1.65% -13.11% -31.96% 10.14% -23.06%
EBIT Margin
-20.25% 7.48% 0.89% -10.67% -18.26% -45.05% -1.65% -13.13% -41.09% 10.53% -16.80%
Profit (Net Income) Margin
-20.58% 7.20% -27.33% -30.38% -37.47% -200.21% 4.05% -14.25% -43.28% 4.81% -13.17%
Tax Burden Percent
101.63% 96.27% 102.24% 101.85% 102.17% 99.50% 153.14% 101.24% 100.05% 97.26% 75.28%
Interest Burden Percent
100.00% 100.00% -3,000.66% 279.49% 200.88% 446.66% -160.50% 107.19% 105.28% 46.99% 104.14%
Effective Tax Rate
0.00% 3.73% 0.00% 0.00% 0.00% 0.00% -53.14% 0.00% 0.00% 2.74% 0.00%
Return on Invested Capital (ROIC)
-11.01% 8.04% 1.19% -21.82% 0.00% 0.00% -11.18% -23.78% -33.85% 26.98% -24.73%
ROIC Less NNEP Spread (ROIC-NNEP)
-14.71% 8.04% -20.17% -47.80% 0.00% 0.00% -34.60% 1.29% 292.65% 88.55% 59.20%
Return on Net Nonoperating Assets (RNNOA)
57.64% -17.09% 38.59% 77.07% 0.00% 0.00% 19.17% -0.44% -25.86% -16.21% 3.39%
Return on Equity (ROE)
46.64% -9.05% 39.78% 55.26% 52.72% 3,694.86% 7.99% -24.23% -59.71% 10.76% -21.33%
Cash Return on Invested Capital (CROIC)
32.90% 67.43% 69.15% 89.29% 0.00% -495.94% -140.41% -64.87% -38.90% 60.00% -113.55%
Operating Return on Assets (OROA)
-8.77% 3.75% 0.44% -5.19% -6.86% -15.23% -1.03% -9.28% -26.50% 12.03% -10.89%
Return on Assets (ROA)
-8.91% 3.61% -13.58% -14.79% -14.07% -67.68% 2.52% -10.07% -27.91% 5.50% -8.54%
Return on Common Equity (ROCE)
49.55% -9.35% 41.77% 59.55% 57.02% 8,555.15% 7.37% -22.85% -55.75% 9.99% -19.96%
Return on Equity Simple (ROE_SIMPLE)
29.91% -9.36% 87.89% 46.10% 81.75% -364.79% 5.37% -24.03% -63.91% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-15 6.51 0.51 -3.93 -3.04 -9.43 -1.42 -6.24 -11 7.71 -11
NOPAT Margin
-14.17% 7.20% 0.75% -7.35% -7.75% -30.02% -2.53% -9.18% -22.37% 9.86% -16.14%
Net Nonoperating Expense Percent (NNEP)
3.70% 0.00% 21.36% 25.99% 42.06% -24,642.35% 23.42% -25.07% -326.50% -61.58% -83.93%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -28.58% 20.39% -16.23%
Cost of Revenue to Revenue
30.76% 29.13% 1.46% 33.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
31.95% 26.30% 42.04% 51.67% 85.24% 120.86% 52.72% 54.12% 56.80% 35.41% 65.88%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
89.48% 63.39% 97.47% 77.36% 111.07% 281.39% 101.65% 113.11% 131.96% 89.86% 123.06%
Earnings before Interest and Taxes (EBIT)
-21 6.76 0.60 -5.71 -7.17 -14 -0.92 -8.93 -20 8.24 -11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
25 43 21 9.93 3.44 -6.01 3.64 -5.00 -16 13 -4.70
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 20.25 3.68 2.05 0.62 1.43 1.15
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.04 4.94 0.00
Price to Revenue (P/Rev)
0.16 0.18 0.71 1.27 0.37 8.82 2.54 1.11 0.38 0.65 0.71
Price to Earnings (P/E)
0.00 2.51 0.00 0.00 0.00 0.00 80.38 0.00 0.00 15.56 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 39.87% 0.00% 0.00% 0.00% 0.00% 1.24% 0.00% 0.00% 6.43% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.87 2.57 3.59 14.31 0.00 59.76 5.97 2.21 0.66 1.64 1.10
Enterprise Value to Revenue (EV/Rev)
1.88 1.62 1.49 2.14 0.71 8.53 2.22 1.03 0.45 0.50 1.04
Enterprise Value to EBITDA (EV/EBITDA)
8.02 3.41 4.87 11.55 8.13 0.00 34.17 0.00 0.00 3.13 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 21.65 166.70 0.00 0.00 0.00 0.00 0.00 0.00 4.75 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 22.48 198.62 0.00 0.00 0.00 0.00 0.00 0.00 5.08 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
7.71 4.61 4.49 10.34 3.60 0.00 25.51 0.00 0.00 2.25 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
4.44 2.68 3.42 7.12 2.10 0.00 0.00 0.00 0.00 2.28 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-2.79 -1.98 -3.06 -1.71 -2.52 0.75 0.00 0.13 0.20 0.00 0.51
Long-Term Debt to Equity
-2.38 -1.62 -2.82 -0.52 0.00 0.14 0.00 0.00 0.00 0.00 0.29
Financial Leverage
-3.92 -2.13 -1.91 -1.61 -0.99 0.13 -0.55 -0.34 -0.09 -0.18 0.06
Leverage Ratio
-5.23 -2.51 -2.93 -3.74 -3.75 -54.59 3.17 2.41 2.14 1.96 2.50
Compound Leverage Factor
-5.23 -2.51 87.92 -10.45 -7.53 -243.84 -5.09 2.58 2.25 0.92 2.60
Debt to Total Capital
155.98% 201.79% 148.50% 241.28% 165.59% 42.82% 0.00% 11.19% 16.39% 0.00% 33.63%
Short-Term Debt to Total Capital
22.55% 37.03% 11.50% 167.36% 165.59% 35.07% 0.00% 11.19% 16.39% 0.00% 14.44%
Long-Term Debt to Total Capital
133.43% 164.76% 137.00% 73.92% 0.00% 7.75% 0.00% 0.00% 0.00% 0.00% 19.20%
Preferred Equity to Total Capital
2.73% 5.12% 7.74% 13.75% 12.10% 12.81% 8.69% 8.09% 9.26% 9.42% 5.45%
Noncontrolling Interests to Total Capital
-0.91% -1.75% -2.73% -4.97% -4.34% -4.90% -3.18% -2.87% -2.92% -2.54% -1.46%
Common Equity to Total Capital
-57.80% -105.16% -53.51% -150.06% -73.35% 49.27% 94.49% 83.59% 77.28% 93.12% 62.38%
Debt to EBITDA
8.30 3.27 3.31 6.29 14.17 -1.98 0.00 -0.98 -0.39 0.00 -4.68
Net Debt to EBITDA
7.26 2.98 2.44 4.49 3.19 1.90 0.00 1.48 -0.07 0.00 -3.96
Long-Term Debt to EBITDA
7.10 2.67 3.05 1.93 0.00 -0.36 0.00 0.00 0.00 0.00 -2.67
Debt to NOPAT
-13.75 21.55 134.94 -15.88 -15.99 -1.26 0.00 -0.79 -0.57 0.00 -2.07
Net Debt to NOPAT
-12.02 19.62 99.47 -11.34 -3.60 1.21 0.00 1.19 -0.10 0.00 -1.75
Long-Term Debt to NOPAT
-11.76 17.59 124.49 -4.87 0.00 -0.23 0.00 0.00 0.00 0.00 -1.18
Altman Z-Score
-2.08 -2.67 -3.63 -5.55 -5.77 -6.43 -4.53 -6.42 -10.86 -7.28 -5.05
Noncontrolling Interest Sharing Ratio
-6.24% -3.28% -5.00% -7.77% -8.15% -131.54% 7.84% 5.69% 6.64% 7.20% 6.41%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.01 0.85 0.97 0.57 0.45 0.75 0.92 0.83 1.05 1.11 0.81
Quick Ratio
0.78 0.65 0.73 0.47 0.38 0.66 0.77 0.62 0.65 0.86 0.67
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
44 55 29 16 13 -22 -18 -17 -13 17 -49
Operating Cash Flow to CapEx
1,846.78% 6,590.23% 2,421.30% 782.50% 627.49% 0.00% 1,543.99% -692.05% -990.83% 26,318.18% -671.15%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 1.57 1.56 1.83 -3.98 0.00 0.00 -11.85 3.93 -106.62
Operating Cash Flow to Interest Expense
0.00 0.00 1.19 1.08 1.07 -3.58 0.00 0.00 -9.94 3.98 -57.98
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 1.14 0.94 0.90 -3.58 0.00 0.00 -10.94 3.96 -66.62
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.43 0.50 0.50 0.49 0.38 0.34 0.62 0.71 0.64 1.14 0.65
Accounts Receivable Turnover
1.86 1.70 1.48 1.45 1.12 1.12 2.16 2.63 2.73 5.07 2.42
Inventory Turnover
12.28 16.66 1.03 24.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.30 1.91 2.48 3.01 3.57 5.48 20.46 35.68 23.91 30.35 19.38
Accounts Payable Turnover
0.44 0.37 0.01 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
196.55 215.03 247.36 251.04 326.51 324.57 169.09 138.67 133.55 72.03 150.91
Days Inventory Outstanding (DIO)
29.73 21.91 355.24 15.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
827.38 985.45 26,316.83 1,418.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
-601.10 -748.51 -25,714.24 -1,152.87 326.51 324.57 169.09 138.67 133.55 72.03 150.91
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
105 57 28 8.01 -8.32 4.48 21 32 33 24 62
Invested Capital Turnover
0.78 1.12 1.59 2.97 -251.87 -16.37 4.42 2.59 1.51 2.74 1.53
Increase / (Decrease) in Invested Capital
-59 -48 -29 -20 -16 13 16 11 1.64 -9.43 38
Enterprise Value (EV)
197 146 101 115 28 268 124 70 22 39 68
Market Capitalization
16 16 48 68 15 277 142 75 19 50 47
Book Value per Share
($0.96) ($6.94) ($0.70) ($1.09) ($0.54) $0.08 $0.22 $0.21 $2.23 $2.20 $2.08
Tangible Book Value per Share
($1.40) ($9.69) ($1.37) ($1.60) ($0.92) ($0.03) ($0.01) ($0.02) $0.34 $0.64 ($1.26)
Total Capital
130 69 46 26 29 28 41 44 38 38 65
Total Debt
203 140 68 62 49 12 0.00 4.92 6.30 0.00 22
Total Long-Term Debt
174 114 63 19 0.00 2.15 0.00 0.00 0.00 0.00 13
Net Debt
178 128 50 45 11 -11 -20 -7.43 1.13 -14 19
Capital Expenditures (CapEx)
1.38 0.48 0.93 1.42 1.24 -0.02 0.32 1.27 1.07 0.07 3.95
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.95 -2.26 -15 -23 -37 -21 -18 -9.98 2.61 -10 -6.18
Debt-free Net Working Capital (DFNWC)
30 10 3.12 -5.52 -22 -4.50 -4.83 -2.83 7.77 3.65 -2.80
Net Working Capital (NWC)
1.01 -15 -2.17 -49 -71 -14 -4.83 -7.75 1.47 3.65 -12
Net Nonoperating Expense (NNE)
6.69 0.00 19 12 12 53 -3.69 3.45 10 3.94 -1.95
Net Nonoperating Obligations (NNO)
178 128 50 45 11 -11 -20 -7.43 1.13 -14 19
Total Depreciation and Amortization (D&A)
46 36 20 16 11 8.14 4.57 3.93 3.96 4.27 6.35
Debt-free, Cash-free Net Working Capital to Revenue
4.74% -2.50% -21.91% -43.69% -93.11% -67.94% -31.92% -14.67% 5.30% -13.17% -9.41%
Debt-free Net Working Capital to Revenue
29.13% 11.41% 4.61% -10.30% -56.73% -14.31% -8.61% -4.16% 15.82% 4.66% -4.25%
Net Working Capital to Revenue
0.97% -17.05% -3.20% -91.22% -180.65% -45.32% -8.61% -11.40% 3.00% 4.66% -18.61%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($130.20) ($38.40) ($16.20) ($8.80) ($6.80) $0.00 $0.20 ($1.13) ($1.78) $0.18 ($0.49)
Adjusted Weighted Average Basic Shares Outstanding
323.40K 619.32K 1.75M 1.79M 2.20M 6.39M 8.53M 8.89M 12.25M 15.81M 18.78M
Adjusted Diluted Earnings per Share
($130.20) ($38.40) ($16.20) ($8.80) ($6.80) ($9.80) $0.20 ($1.13) ($1.78) $0.16 ($0.49)
Adjusted Weighted Average Diluted Shares Outstanding
323.40K 619.32K 1.75M 1.79M 2.20M 6.39M 8.69M 8.89M 12.25M 17.82M 18.78M
Adjusted Basic & Diluted Earnings per Share
($130.20) ($38.40) ($16.20) ($8.80) ($6.80) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
323.40K 402.46K 1.16M 1.90M 2.20M 6.39M 8.84M 11.68M 15.61M 17.11M 23.42M
Normalized Net Operating Profit after Tax (NOPAT)
-2.97 6.59 0.51 -3.93 -3.04 -9.43 0.73 -6.24 -1.17 7.71 -11
Normalized NOPAT Margin
-2.84% 7.29% 0.75% -7.35% -7.75% -30.02% 1.30% -9.18% -2.39% 9.86% -16.14%
Pre Tax Income Margin
-20.25% 7.48% -26.73% -29.83% -36.68% -201.22% 2.65% -14.08% -43.26% 4.95% -17.50%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.03 -0.56 -0.99 -2.53 0.00 0.00 -18.94 1.89 -24.16
NOPAT to Interest Expense
0.00 0.00 0.03 -0.38 -0.42 -1.69 0.00 0.00 -10.31 1.77 -23.21
EBIT Less CapEx to Interest Expense
0.00 0.00 -0.02 -0.69 -1.16 -2.53 0.00 0.00 -19.94 1.87 -32.80
NOPAT Less CapEx to Interest Expense
0.00 0.00 -0.02 -0.52 -0.59 -1.69 0.00 0.00 -11.31 1.75 -31.85
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
5.43% -0.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-60.22% -0.60% -0.88% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.26% -9.37%

Quarterly Metrics And Ratios for Cineverse

This table displays calculated financial ratios and metrics derived from Cineverse's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
13,327,960.00 15,606,341.00 15,706,341.00 15,873,119.00 15,979,558.00 17,108,062.00 19,075,264.00 19,150,403.00 19,569,866.00 23,417,021.00 23,771,387.00
DEI Adjusted Shares Outstanding
13,327,960.00 15,606,341.00 15,706,341.00 15,873,119.00 15,979,558.00 17,108,062.00 19,075,264.00 19,150,403.00 19,569,866.00 23,417,021.00 23,771,387.00
DEI Earnings Per Adjusted Shares Outstanding
-1.11 -0.20 -0.09 0.44 0.05 -0.21 -0.30 -0.05 0.06 -0.25 0.13
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.40% -29.68% -2.10% 206.87% 57.91% 21.83% -3.00% -60.02% 66.75% 175.16% 110.04%
EBITDA Growth
-222.07% 29.85% -75.65% 839.02% 125.29% -59.99% -2,038.79% -94.58% -54.78% 26.41% 275.42%
EBIT Growth
-186.66% 18.91% -711.32% 485.14% 115.27% -44.72% -525.35% -106.95% -155.69% -35.26% 175.49%
NOPAT Growth
-356.64% -2.25% -246.93% 3,054.27% 119.71% -33.26% -528.34% -104.87% -295.34% -38.41% 203.48%
Net Income Growth
-377.42% 13.74% -279.50% 361.73% 105.83% -15.28% -360.93% -112.22% 49.42% -61.83% 158.59%
EPS Growth
-236.11% 45.95% -125.00% 254.55% 104.13% -5.00% -244.44% -114.71% 60.00% -33.33% 135.48%
Operating Cash Flow Growth
-45.81% 28.10% 97.08% 336.88% 1,052.11% -519.62% -8,336.47% -121.87% -125.67% 93.07% 61.06%
Free Cash Flow Firm Growth
11.55% 78.94% 117.63% 231.79% 199.37% -121.97% -478.47% -158.86% -468.56% -258.31% -148.64%
Invested Capital Growth
5.18% 3.94% -9.39% -17.41% -28.34% 13.59% 21.45% 27.28% 159.80% 57.94% 76.08%
Revenue Q/Q Growth
-25.71% -7.46% 39.57% 219.81% -61.77% -28.61% 11.13% 31.80% 59.47% 17.80% -15.17%
EBITDA Q/Q Growth
-831.75% 87.60% 112.95% 4,838.32% -68.11% -178.43% -56.98% 113.81% 165.97% -227.62% 474.19%
EBIT Q/Q Growth
-482.95% 81.85% 67.08% 1,205.70% -76.89% -271.97% -42.28% 87.71% -85.17% -317.73% 179.41%
NOPAT Q/Q Growth
-3,377.75% 80.15% 69.01% 1,664.31% -79.52% -234.22% -46.14% 87.87% -721.34% 4.90% 209.26%
Net Income Q/Q Growth
-436.40% 79.22% 60.56% 695.26% -88.05% -510.75% -57.71% 84.22% 246.17% -544.88% 157.10%
EPS Q/Q Growth
-450.00% 83.47% 55.00% 477.78% -85.29% -520.00% -47.62% 83.87% 260.00% -450.00% 139.29%
Operating Cash Flow Q/Q Growth
58.08% -79.62% 96.37% 8,775.29% 68.50% -216.87% 50.63% 77.51% -97.71% 68.83% -188.03%
Free Cash Flow Firm Q/Q Growth
9.44% 71.98% 191.63% 466.84% -31.72% -162.59% -56.23% 11.85% -327.57% 39.15% -8.41%
Invested Capital Q/Q Growth
-19.68% -0.03% 2.62% 0.24% -30.32% 58.47% 9.72% 5.04% 42.24% -3.66% 22.32%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-135.09% -18.10% 1.68% 25.94% 21.64% -23.77% -33.58% 3.52% 5.87% -6.36% 28.04%
Operating Margin
-141.90% -30.44% -6.76% 23.16% 13.66% -33.29% -43.78% -4.03% -20.75% -16.75% 15.62%
EBIT Margin
-145.93% -28.62% -6.75% 23.34% 14.11% -34.00% -43.52% -4.06% -4.71% -16.71% 15.64%
Profit (Net Income) Margin
-148.80% -33.42% -9.44% 17.58% 5.50% -31.62% -44.87% -5.37% 4.92% -18.60% 12.52%
Tax Burden Percent
99.99% 100.23% 100.50% 99.92% 90.77% 100.40% 100.36% 102.22% -79.10% 100.34% 96.67%
Interest Burden Percent
101.98% 116.50% 139.19% 75.37% 42.90% 92.65% 102.73% 129.50% 132.11% 110.91% 82.78%
Effective Tax Rate
0.00% 0.00% 0.00% 0.08% 9.23% 0.00% 0.00% 0.00% 0.00% 0.00% 3.33%
Return on Invested Capital (ROIC)
-150.33% -29.55% -5.93% 44.33% 33.93% -52.58% -64.68% -4.01% -22.25% -20.49% 26.06%
ROIC Less NNEP Spread (ROIC-NNEP)
4.70% -3.61% 36.30% 154.38% 50.71% -86.32% -101.06% -27.21% 194.89% -40.27% 21.02%
Return on Net Nonoperating Assets (RNNOA)
-0.42% 0.42% -1.38% -7.97% -9.29% -7.21% -14.81% -1.31% 11.17% -11.23% 6.35%
Return on Equity (ROE)
-150.74% -29.13% -7.31% 36.35% 24.64% -59.79% -79.48% -5.33% -11.08% -31.73% 32.41%
Cash Return on Invested Capital (CROIC)
-38.90% -37.66% -23.69% 3.90% 60.00% 6.32% -14.84% -37.76% -113.55% -68.73% -63.81%
Operating Return on Assets (OROA)
-94.11% -17.16% -4.18% 20.66% 16.12% -44.00% -56.67% -3.01% -3.06% -14.48% 16.08%
Return on Assets (ROA)
-95.96% -20.04% -5.85% 15.56% 6.28% -40.93% -58.43% -3.99% 3.19% -16.11% 12.86%
Return on Common Equity (ROCE)
-140.73% -27.25% -6.83% 34.09% 22.87% -55.14% -73.18% -4.94% -10.37% -29.28% 30.34%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-9.80 -1.94 -0.60 9.43 1.93 -2.59 -3.79 -0.46 -3.77 -3.59 3.92
NOPAT Margin
-99.33% -21.31% -4.73% 23.14% 12.40% -23.31% -30.65% -2.82% -14.52% -11.72% 15.10%
Net Nonoperating Expense Percent (NNEP)
-155.03% -25.94% -42.23% -110.05% -16.78% 33.74% 36.38% 23.20% -217.14% 19.78% 5.04%
Return On Investment Capital (ROIC_SIMPLE)
-25.48% -5.22% -1.65% 23.39% 5.11% -6.51% -8.64% -1.00% -5.77% -5.60% 5.12%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
69.11% 71.91% 49.96% 22.98% 34.65% 80.51% 92.31% 65.64% 47.20% 37.97% 39.06%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
241.90% 130.44% 106.76% 76.84% 86.34% 133.29% 143.78% 104.03% 120.75% 116.75% 84.38%
Earnings before Interest and Taxes (EBIT)
-14 -2.61 -0.86 9.51 2.20 -3.78 -5.38 -0.66 -1.22 -5.11 4.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-13 -1.65 0.21 11 3.37 -2.64 -4.15 0.57 1.52 -1.95 7.28
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.62 0.44 0.59 1.71 1.43 2.44 1.86 1.15 1.15 1.89 0.99
Price to Tangible Book Value (P/TBV)
4.04 6.11 10.18 6.28 4.94 9.90 6.91 3.86 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.38 0.26 0.34 0.80 0.65 1.02 0.80 0.73 0.71 0.82 0.48
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 15.56 29.64 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 6.43% 3.37% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.66 0.55 0.68 1.70 1.64 2.28 1.71 1.12 1.10 1.55 1.00
Enterprise Value to Revenue (EV/Rev)
0.45 0.40 0.52 0.80 0.50 1.07 0.89 0.88 1.04 1.08 0.74
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 3.13 7.48 9.95 0.00 0.00 0.00 9.79
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 4.75 12.18 27.89 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 5.08 12.72 41.43 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 16.01 2.25 16.45 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 39.48 2.28 38.32 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.20 0.26 0.27 0.11 0.00 0.10 0.18 0.22 0.51 0.60 0.51
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.29 0.31 0.28
Financial Leverage
-0.09 -0.12 -0.04 -0.05 -0.18 0.08 0.15 0.05 0.06 0.28 0.30
Leverage Ratio
2.14 2.05 1.95 2.05 1.96 1.89 1.86 2.01 2.50 2.58 2.19
Compound Leverage Factor
2.18 2.38 2.71 1.55 0.84 1.75 1.91 2.60 3.30 2.86 1.81
Debt to Total Capital
16.39% 20.93% 21.28% 9.54% 0.00% 9.12% 15.17% 17.99% 33.63% 37.40% 33.72%
Short-Term Debt to Total Capital
16.39% 20.93% 21.28% 9.54% 0.00% 9.12% 15.17% 17.99% 14.44% 17.74% 15.02%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 19.20% 19.66% 18.70%
Preferred Equity to Total Capital
9.26% 9.56% 9.73% 8.83% 9.42% 8.95% 8.12% 7.73% 5.45% 5.07% 3.82%
Noncontrolling Interests to Total Capital
-2.92% -2.95% -2.78% -2.40% -2.54% -2.30% -1.99% -1.79% -1.46% 0.00% 0.00%
Common Equity to Total Capital
77.28% 72.46% 71.76% 84.03% 93.12% 84.24% 78.70% 76.06% 62.38% 57.53% 62.46%
Debt to EBITDA
-0.39 -0.50 -0.48 -0.92 0.00 0.32 0.93 -2.91 -4.68 -5.99 3.47
Net Debt to EBITDA
-0.07 -0.25 -0.33 0.53 0.00 0.14 0.60 -2.04 -3.96 -4.91 3.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.67 -3.15 1.93
Debt to NOPAT
-0.57 -0.71 -0.65 -0.67 0.00 0.54 3.87 -1.55 -2.07 -2.06 -5.18
Net Debt to NOPAT
-0.10 -0.35 -0.44 0.39 0.00 0.24 2.51 -1.09 -1.75 -1.69 -4.47
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.18 -1.08 -2.88
Altman Z-Score
-10.57 -10.61 -10.79 -6.54 -7.56 -8.45 -9.00 -8.90 -4.80 -4.57 -4.38
Noncontrolling Interest Sharing Ratio
6.64% 6.46% 6.55% 6.24% 7.20% 7.78% 7.93% 7.18% 6.41% 7.72% 6.39%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.05 0.97 0.96 1.15 1.11 0.99 0.95 0.95 0.81 0.75 0.83
Quick Ratio
0.65 0.41 0.55 0.92 0.86 0.72 0.66 0.65 0.67 0.64 0.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-11 -3.20 2.94 17 11 -7.11 -11 -9.80 -42 -25 -28
Operating Cash Flow to CapEx
-304.91% 0.00% 0.00% 0.00% 62,125.00% -90,775.00% -1,448.69% -2,041.77% -94.97% -365.44% -730.36%
Free Cash Flow to Firm to Interest Expense
-40.13 -7.44 8.71 7.11 9.06 0.00 -75.60 -50.24 -106.58 -45.68 -39.53
Operating Cash Flow to Interest Expense
-4.58 -5.44 -0.25 3.15 9.90 0.00 -48.78 -8.27 -8.11 -1.78 -4.10
Operating Cash Flow Less CapEx to Interest Expense
-6.08 -5.44 -0.25 3.50 9.88 0.00 -52.15 -8.68 -16.66 -2.27 -4.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.64 0.60 0.62 0.89 1.14 1.29 1.30 0.74 0.65 0.87 1.03
Accounts Receivable Turnover
2.73 3.78 3.31 2.88 5.07 6.33 5.59 2.16 2.42 2.88 4.11
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
23.91 18.88 17.99 29.03 30.35 28.18 26.59 17.15 19.38 23.91 26.47
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
133.55 96.63 110.26 126.81 72.03 57.67 65.33 169.31 150.91 126.64 88.79
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
133.55 96.63 110.26 126.81 72.03 57.67 65.33 169.31 150.91 126.64 88.79
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
33 33 34 34 24 38 41 44 62 60 73
Invested Capital Turnover
1.51 1.39 1.25 1.92 2.74 2.26 2.11 1.42 1.53 1.75 1.73
Increase / (Decrease) in Invested Capital
1.64 1.26 -3.54 -7.22 -9.43 4.52 7.33 9.34 38 22 32
Enterprise Value (EV)
22 18 23 58 39 86 71 49 68 92 73
Market Capitalization
19 12 15 58 50 82 64 40 47 70 48
Book Value per Share
$2.23 $2.02 $1.67 $2.13 $2.20 $2.10 $1.81 $1.83 $2.08 $1.57 $2.01
Tangible Book Value per Share
$0.34 $0.15 $0.10 $0.58 $0.64 $0.52 $0.49 $0.55 ($1.26) ($1.13) ($0.63)
Total Capital
38 37 37 40 38 40 44 46 65 64 77
Total Debt
6.30 7.79 7.78 3.85 0.00 3.63 6.65 8.28 22 24 26
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13 13 14
Net Debt
1.13 3.84 5.36 -2.24 -14 1.64 4.31 5.82 19 20 22
Capital Expenditures (CapEx)
0.43 0.00 0.00 -0.82 0.02 0.02 0.50 0.08 3.36 0.27 0.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2.61 2.94 4.16 4.52 -10 1.37 3.04 4.41 -6.18 -12 -1.75
Debt-free Net Working Capital (DFNWC)
7.77 6.90 6.59 11 3.65 3.35 5.38 6.87 -2.80 -7.52 1.80
Net Working Capital (NWC)
1.47 -0.90 -1.20 6.76 3.65 -0.28 -1.27 -1.41 -12 -19 -9.70
Net Nonoperating Expense (NNE)
4.88 1.11 0.60 2.27 1.07 0.92 1.76 0.42 -5.05 2.10 0.67
Net Nonoperating Obligations (NNO)
1.13 3.84 5.36 -2.24 -14 1.64 4.31 5.82 19 20 22
Total Depreciation and Amortization (D&A)
1.07 0.96 1.07 1.06 1.17 1.14 1.23 1.23 2.75 3.17 3.22
Debt-free, Cash-free Net Working Capital to Revenue
5.30% 6.49% 9.24% 6.24% -13.17% 1.71% 3.81% 7.96% -9.41% -13.90% -1.78%
Debt-free Net Working Capital to Revenue
15.82% 15.23% 14.63% 14.63% 4.66% 4.18% 6.74% 12.41% -4.25% -8.83% 1.82%
Net Working Capital to Revenue
3.00% -1.98% -2.66% 9.32% 4.66% -0.34% -1.59% -2.55% -18.61% -22.16% -9.82%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.21) ($0.20) ($0.09) $0.38 $0.05 ($0.21) ($0.31) ($0.05) $0.08 ($0.28) $0.13
Adjusted Weighted Average Basic Shares Outstanding
12.25M 15.70M 15.72M 15.88M 15.81M 16.99M 18.45M 19.22M 18.78M 20.67M 24.28M
Adjusted Diluted Earnings per Share
($1.21) ($0.20) ($0.09) $0.34 $0.05 ($0.21) ($0.31) ($0.05) $0.08 ($0.28) $0.11
Adjusted Weighted Average Diluted Shares Outstanding
12.25M 15.70M 15.72M 17.77M 17.82M 16.99M 18.45M 19.22M 18.78M 20.67M 32.34M
Adjusted Basic & Diluted Earnings per Share
($1.21) $0.00 $0.00 $0.00 $0.05 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.61M 15.71M 15.87M 15.98M 17.11M 19.08M 19.15M 19.57M 23.42M 23.77M 26.82M
Normalized Net Operating Profit after Tax (NOPAT)
-9.80 -1.94 -0.60 9.43 1.93 -2.59 -3.79 -0.46 -3.77 -3.59 3.92
Normalized NOPAT Margin
-99.33% -21.31% -4.73% 23.14% 12.40% -23.31% -30.65% -2.82% -14.52% -11.72% 15.10%
Pre Tax Income Margin
-148.82% -33.34% -9.40% 17.59% 6.05% -31.50% -44.71% -5.26% -6.23% -18.54% 12.95%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-50.50 -6.06 -2.55 4.06 1.75 0.00 -36.59 -3.39 -3.11 -9.16 5.81
NOPAT to Interest Expense
-34.38 -4.51 -1.79 4.03 1.54 0.00 -25.76 -2.35 -9.60 -6.43 5.61
EBIT Less CapEx to Interest Expense
-52.00 -6.06 -2.55 4.41 1.74 0.00 -39.95 -3.79 -11.66 -9.65 5.25
NOPAT Less CapEx to Interest Expense
-35.88 -4.51 -1.79 4.37 1.52 0.00 -29.13 -2.76 -18.14 -6.92 5.05
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.90% -0.99% -1.83% 11.26% 0.82% 0.00% 0.00% -9.37% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Cineverse’s recent financial statements show a company with improving revenue momentum but continued profitability and liquidity challenges. Results are also volatile, with reported revenue ranging from approximately $9.1 million to $40.7 million across the periods provided. The latest quarter, Q1 fiscal 2027 ended June 30, 2026, included $30.6 million of revenue, up from $26.0 million in the prior quarter and $11.1 million in the year-ago quarter.

  • Revenue growth has accelerated. Q1 fiscal 2027 revenue increased approximately 18% sequentially and 175% year over year based on the supplied quarterly figures. Revenue has also risen substantially from the $9 million to $13 million range reported during much of fiscal 2025.
  • Operating cash burn has improved. Cash flow from operations was negative $994,000 in Q1 fiscal 2027, compared with negative $3.2 million in Q4 fiscal 2026, negative $1.6 million in Q3 fiscal 2026 and negative $7.2 million in Q2 fiscal 2026.
  • The company has increased its asset base. Total assets rose to $135.2 million in Q1 fiscal 2027 from $68.6 million in Q3 fiscal 2026. Goodwill and intangible assets accounted for much of the increase, which may reflect acquisitions and expanded content or intellectual-property holdings.
  • Debt maturity has been extended through active refinancing. Cineverse issued $18.8 million of debt in Q1 fiscal 2027 while repaying $16.9 million, producing $1.9 million of net debt issuance. This financing activity helped the company increase cash by $951,000 during the quarter.
  • Revenue recognition and operating results are highly uneven. The $40.7 million reported in Q3 fiscal 2025 was substantially above surrounding quarters, while revenue fell to $11.1 million in Q1 fiscal 2026 before recovering. Investors should be cautious about extrapolating the latest growth rate without additional quarters of confirmation.
  • Gross margin data should be interpreted carefully. The standardized statements report no cost of revenue, causing gross profit to equal revenue in every listed period. This produces a seemingly 100% gross margin but does not necessarily represent the company’s full economic content and distribution costs.
  • Cineverse remains unprofitable. Q1 fiscal 2027 produced an operating loss of $5.1 million and a net loss attributable to common shareholders of $5.8 million, or $0.28 per share. This followed a $1.1 million gain attributable to common shareholders in Q4 fiscal 2026.
  • Operating expenses remain heavy and volatile. Q1 fiscal 2027 operating expenses totaled $35.7 million, including $21.3 million of other operating expenses. Those costs exceeded the company’s $30.6 million of revenue and pushed the business back into an operating loss despite stronger sales.
  • Liquidity is weak relative to short-term obligations. Cash and equivalents were only $4.3 million at June 30, 2026, while current liabilities were $74.4 million. Accounts receivable increased sharply to $43.1 million, meaning a large portion of current assets is tied up in amounts that must still be collected. The reported current ratio was approximately 0.75.
  • The balance sheet continues to carry substantial accumulated losses. Retained earnings were negative $515.9 million, while total debt was approximately $24.2 million. Although total equity was $40.1 million, the company’s history of losses and reliance on debt and equity financing remain important risks for shareholders.

Overall, Cineverse’s growth profile is encouraging, and the reduction in operating cash burn is a constructive development. However, the company has not yet demonstrated consistent operating profitability or the ability to fund operations internally. Retail investors should closely monitor whether revenue remains elevated, whether the unusually large operating expense line moderates, and whether cash flow can turn positive without additional borrowing or equity issuance.

11/20/26 10:32 AM ETAI Generated. May Contain Errors.

Cineverse Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cineverse's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Cineverse's net income appears to be on an upward trend, with a most recent value of -$8.66 million in 2026, rising from -$21.49 million in 2016. The previous period was $3.76 million in 2025. Check out Cineverse's forecast to explore projected trends and price targets.

Cineverse's total operating income in 2026 was -$15.16 million, based on the following breakdown:
  • Total Gross Profit: $65.73 million
  • Total Operating Expenses: $80.89 million

Over the last 10 years, Cineverse's total revenue changed from $104.45 million in 2016 to $65.73 million in 2026, a change of -37.1%.

In the past 12 quarters, Cineverse's cash and equivalents has ranged from $1.99 million in Q1 2026 to $8.62 million in Q2 2024, and is currently $3.55 million as of their latest financial filing in Q2 2027.

Cineverse had total debt of $21.98 million at the end of 2026, compared with none in 2025, and a 89.2% decrease since 2016.

Over the last 10 years, Cineverse's book value per share changed from -0.96 in 2016 to 2.08 in 2026.



Financial statements for NASDAQ:CNVS last updated on 11/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners